分析师削减了Vitalhub 2025年的收入预测, Analysts cut Vitalhub's 2025 earnings forecast amid weak stock performance and high valuation.

来自Cormark和Roth Capital的分析师降低了对Vitalhub的2025年收入预测,Cormark将EPS的估计数削减至0.06美元,Roth的估计数削减至0.08美元,并引述了订正业绩预期。 Analysts from Cormark and Roth Capital have lowered their 2025 earnings forecasts for Vitalhub, with Cormark cutting its EPS estimate to $0.06 and Roth to $0.08, citing revised performance expectations. 尽管进行了修订,但一致的欧洲证券局当年估计值仍为0.23美元,股票的“Buy”评级是“Buy”,目标价格为14.86科多巴。 Despite the revisions, the consensus EPS estimate for the year remains at $0.23, and the stock holds a "Buy" rating with a target price of C$14.86. 截至2025年11月12日,Vitalhub交易额为9.29科多巴元,接近52周最低点,低于关键移动平均数,P/E比率高达116.13。 As of November 12, 2025, Vitalhub traded at C$9.29, near its 52-week low, below key moving averages, and with a high P/E ratio of 116.13. 该公司是加拿大的保健技术提供者,为心理健康、长期护理和急性护理部门提供数字解决方案。 The company, a Canadian health tech provider, serves mental health, long-term care, and acute care sectors with digital solutions. 两名董事在8月出售股票,内幕人士拥有公司18.57%的股份。 Two directors sold shares in August, and insiders own 18.57% of the company.